Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Mathias Uhlén’s protein atlas is recognised as a global resource

The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...

Kristdemokraterna rekryterar från Sanofi

Jonas Sareld, Public Affairs Manager vid Sanofi, blir kanslichef för Kristdemokraterna i Region Stockholm.

Rapid development in blood analysis – “Sweden is leading the race”

Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor...

“Photon counting in computed tomography is the holy grail”

Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...

Pharma Outsourcing igång på Stockholm Waterfront

Dylan Ceynowa är ny medicinsk chef på Novocure

Cancerterapibolaget Novocure har rekryterat Dylan Ceynowa till tjänsten som Senior Medical Manager.

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

The art of building a biologic drug

The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...

Swedish breakthrough in Alzheimer’s: “We can finally present great data”

Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...

Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”

The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from AB...

Höstens mest lästa krönikor

Här nedan läser du de mest lästa krönikorna i Life Science Sweden och systertidningen Medtech Magazine från hösten och vintern.

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

Ny chef på Key2compliance: “Lite mindre konventionell”

Affärsutvecklaren och projektledaren Jeanette Demorney blir ny affärsområdeschef för clinical development på Key2compliance.

Ny vd för AOP Orphan Pharmaceuticals

AOP Orphan Pharmaceuticals har utsett Sofia Opitz till ny vd. Hon kommer närmast från en tjänst som Country Manager för Sverige, Norge och Danmark på företaget Biocodex.

Arne Thuresson Byggmaterial väljer Jeeves ERP Cloud

Arne Thuresson Byggmaterial AB i Spånga har valt Jeeves som leverantör av sitt nya affärssystem.

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a well-advanced project...

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Har du den bästa branschlösningen för kemiindustrin?

Har du också märkt av en ökad mängd branschspecifika regler och direktiv, ökad global konkurrens och ännu högre kvalitetskrav? Dessutom en ökad kostnadskontroll...